CoChat

Clinical Outcome with Oral Linezolid and Rifampin Following Recurrent Methicillin‐Resistant Staphylococcus aureus Bacteremia Despite Prolonged Vancomycin Treatment

Open access
Schwalm, Jon-David, El-Helou, Philippe, Lee, Christine H · 2004 · Canadian Journal of Infectious Diseases and Medical Microbiology

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Drug‐resistant Gram‐positive bacteria, especially Staphylococcus aureus, are emerging as the predominant organisms involved in both nosocomial and community‐acquired infections. Since the 1980s, vancomycin has been the first‐line antibiotic used to treat methicillin‐resistant S aureus. However, allergy and intolerance to vancomycin, the increasing number of vancomycin clinical failures and the existence of vancomycin intermediate‐susceptible isolates of S aureus suggest that new antibiotics are needed. This paper reports the only known case of a successful clinical outcome with long term oral linezolid and rifampin therapy in the management of recurrent and persistent methicillin‐resistant S aureus bacteremia with metastatic infections despite prolonged vancomycin use. More than two years since the initiation of linezolid and rifampin, the study patient has been clinically well with no evidence of adverse drug reactions including cytopenia and hepatic toxicities. Physicians must be aware of the novel developments in antibiotic therapy to treat drug‐resistant bacterial infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2004/768765

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 ) Febrile illness in relation to antibiotic therapy (*Temperature approximated to represent presence or absence of fever). Vanco Vancomycin
Figure 1 ) Febrile illness in relation to antibiotic therapy (*Temperature approximated to represent presence or absence of fever). Vanco VancomycinCC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
Image 7
CC-BY · From the PDF
Image 8
CC-BY · From the PDF
Image 9
CC-BY · From the PDF
Image 10
CC-BY · From the PDF
Image 11
CC-BY · From the PDF
Image 12
CC-BY · From the PDF
Image 13
CC-BY · From the PDF
Image 14
CC-BY · From the PDF
Image 15
CC-BY · From the PDF
Image 16
CC-BY · From the PDF
Image 17
CC-BY · From the PDF
Image 18
CC-BY · From the PDF
Image 19
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. [3]3. Chang FY. Staphylococcus aureus bacteremia and endocarditis. J Microbiol Immunol Infect 2000;33:63-8.
  2. [12]12. Niitsuma K, Saito M. Vancomycin inhalation therapy - A pharmacokinetic and clinical study of vancomycin. Antibiot Chemother 1996;122:123-35.
  3. [35]35. Kaatz GW, Seo SM. In vitro activities of oxazolidinone compound U-100592 and U-100766 against S aureus and S epidermidis. Antimicrob Agents Chemother 1996;40:799-801.

Cited by

See all 16

Metadata

Authors
Schwalm, J.-D., El-Helou, P., & Lee, C. H.
Affiliations
McMaster University (CA)
Corresponding author
Lee, Christine H
Venue
Canadian Journal of Infectious Diseases and Medical Microbiology
Publisher
Wiley
Published
2004-01
Volume
15
Issue
2
Pages
97-100
ISSN
  • 1180-2332 (ISSN-L)
  • 1712-9532
  • 1918-1493
OpenAlex
W2317216373
Cited by
16
References
45
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2021: 1 · 2020: 1 · 2018: 1 · 2016: 1 · 2015: 2 · 2013: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Canadian Journal of Infectious Diseases and Medical Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
methicillin-resistant Staphylococcus aureus, MRSA bacteremia, recurrent bacteremia, linezolid, rifampicin, oral antibiotic therapy, vancomycin resistance, vancomycin intermediate resistance, metastatic infection, adverse drug reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.